The UK organisation NICE I think is doing well in establishing rational practices for drugs which the UK's National Health Service should or should not buy, at what price and whether there should be sharing of risk dependent on patient outcome. It's had some early controversy, but I think most people would say that it's doing a good job. So I think there are approaches to finding solutions and working out whether or not a drug is worth the price.

Congratulations! Your blog is excellent and deserves lots of views. Your opinions and questions are very thoughtful and focus on what really matters. I wish we had more sites in the UK and Europe that could provide such analysis for what is happening here. Today, my much more humble blog finally made it to 200 views, which I'm quite happy about. I wish you continued success.